12 Healthcare Stocks with Insider Buying in 2025

Page 6 of 10

5. BGM Group Ltd. (NASDAQ:BGM)

Insider Shares: 72.94%

BGM Group Ltd. (NASDAQ:BGM), a China-based pharmaceutical and chemical company, is rapidly transforming into an AI- and biopharma-focused enterprise. Through subsidiaries, the company develops specialty and generic drugs while expanding into intelligent robotics and healthcare technology.

In 2025, BGM reported a 271% surge in total assets to $207.4 million as of March 31, fueled by acquisitions such as Patriton Limited and HM Management Company Limited. BGM Group Ltd. (NASDAQ:BGM) also acquired Xingdao Intelligent, specializing in AI-powered robotics, and YD Network, focused on AI in stock trading. Despite this expansion, the firm posted a net loss of $0.9 million in the first half of 2025, reflecting the high costs of its transformation.

The corporation is also strengthening its healthcare presence through the acquisition of Wonder Dragon Global, which adds inventories of Qingzhuan dark tea. BGM plans to leverage AI to develop health-focused products, including ginseng and goji berry tea variants with potential medicinal applications. Leadership changes this year saw the CEO assume the chairman role to align governance with BGM’s technology-driven strategy.

In September 2025, institutional investors have shown interest in BGM Group Ltd. (NASDAQ:BGM)’s pivot, and insiders have increased their holdings, signaling confidence in the company’s future. Shares have gained over 35% in the past month, reflecting optimism around its strategic shift, though the stock remains volatile. Looking ahead, the business has allocated $1.4 million for capital expenditures to scale AI and biopharma operations, with a focus on cost efficiency and expanding its multi-agent AI productivity platform.

Page 6 of 10